Anal canal cancer and chemoradiation treatment in two patients with systemic lupus erythematosus treated by chronic therapeutic immunosuppression.

2.50
Hdl Handle:
http://hdl.handle.net/10541/77972
Title:
Anal canal cancer and chemoradiation treatment in two patients with systemic lupus erythematosus treated by chronic therapeutic immunosuppression.
Authors:
Khoo, Vincent S; Saunders, Mark P; Gowda, R; Price, Patricia M; Cummings, B J
Abstract:
Two case reports of anal cancer developing during chronic therapeutic immunosuppression for systemic lupus erythematosus (SLE) and their cancer management are presented. The complex issues of delivery of curative chemoradiation treatment for anal cancer in the context of co-existing autoimmune connective tissue disease (AICD) are discussed. These two cases show that combined chemotherapy and radiation regimens are possible in patients with SLE. However, frequent, careful assessment with judicious and prompt management of haematological and other complications during treatment is important.
Affiliation:
Department of Academic Radiation Oncology, Christie Hospital NHS Trust, Manchester, UK. vincent.khoo@man.ac.uk
Citation:
Anal canal cancer and chemoradiation treatment in two patients with systemic lupus erythematosus treated by chronic therapeutic immunosuppression. 2004, 16 (1):1-5 Clin Oncol
Journal:
Clinical Oncology
Issue Date:
Feb-2004
URI:
http://hdl.handle.net/10541/77972
DOI:
10.1016/S0936-6555(03)00200-0
PubMed ID:
14768748
Type:
Article
Language:
en
ISSN:
0936-6555
Appears in Collections:
All Christie Publications

Full metadata record

DC FieldValue Language
dc.contributor.authorKhoo, Vincent S-
dc.contributor.authorSaunders, Mark P-
dc.contributor.authorGowda, R-
dc.contributor.authorPrice, Patricia M-
dc.contributor.authorCummings, B J-
dc.date.accessioned2009-08-20T11:56:27Z-
dc.date.available2009-08-20T11:56:27Z-
dc.date.issued2004-02-
dc.identifier.citationAnal canal cancer and chemoradiation treatment in two patients with systemic lupus erythematosus treated by chronic therapeutic immunosuppression. 2004, 16 (1):1-5 Clin Oncolen
dc.identifier.issn0936-6555-
dc.identifier.pmid14768748-
dc.identifier.doi10.1016/S0936-6555(03)00200-0-
dc.identifier.urihttp://hdl.handle.net/10541/77972-
dc.description.abstractTwo case reports of anal cancer developing during chronic therapeutic immunosuppression for systemic lupus erythematosus (SLE) and their cancer management are presented. The complex issues of delivery of curative chemoradiation treatment for anal cancer in the context of co-existing autoimmune connective tissue disease (AICD) are discussed. These two cases show that combined chemotherapy and radiation regimens are possible in patients with SLE. However, frequent, careful assessment with judicious and prompt management of haematological and other complications during treatment is important.en
dc.language.isoenen
dc.subjectAnus Canceren
dc.subject.meshAdult-
dc.subject.meshAntineoplastic Combined Chemotherapy Protocols-
dc.subject.meshAnus Neoplasms-
dc.subject.meshCombined Modality Therapy-
dc.subject.meshFemale-
dc.subject.meshHumans-
dc.subject.meshImmunosuppressive Agents-
dc.subject.meshLupus Erythematosus, Systemic-
dc.subject.meshMiddle Aged-
dc.subject.meshTreatment Outcome-
dc.titleAnal canal cancer and chemoradiation treatment in two patients with systemic lupus erythematosus treated by chronic therapeutic immunosuppression.en
dc.typeArticleen
dc.contributor.departmentDepartment of Academic Radiation Oncology, Christie Hospital NHS Trust, Manchester, UK. vincent.khoo@man.ac.uken
dc.identifier.journalClinical Oncologyen

Related articles on PubMed

All Items in Christie are protected by copyright, with all rights reserved, unless otherwise indicated.